| Bioactivity | LN002 is an orally active anti-Cryptosporidium oxidase inhibitor for the study of cryptosporidiosis[1]. |
| CAS | 321372-40-1 |
| Formula | C22H15N7 |
| Molar Mass | 377.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Minglang Ma, et al. "Pharmacokinetics and tissue distribution of LN002, a new compound alternative oxidase inhibitor against Cryptosporidium in rats." Frontiers in Pharmacology 15 (2024): 1413872. |